Trials such as STRONG-HF, TRANSITION, and PIONEER-HF underscore the benefits of rapid up-titration of GDMT, including reductions in NT-proBNP levels and hospital readmissions[203,210]. This evidence concerns the gene NPPB and hydrops fetalis.